Lundbeck Inc. Announces the Voluntary Nationwide Recall of Two Lots of NeoProfen® (ibuprofen lysine) Injection
July 31st, 2010 · No Comments
– Lundbeck Inc. has voluntarily recalled two lots of NeoProfen® (ibuprofen lysine) Injection that failed to meet a visible particulate quality requirement. These two lots are the only lots currently available to prescribers and therefore the recall will result in a temporary drug shortage.
Tags: FDA · FDA Recalls
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.
You must log in to post a comment.